RG
Rathbones Group’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
128,616
-499,459
| -80% | -$39.1M | 0.04% | 162 |
|
|
2025
Q1 | $45.5M | Sell |
628,075
-671,096
| -52% | -$48.6M | 0.22% | 98 |
|
|
2024
Q4 | $96.2M | Buy |
1,299,171
+15,192
| +1% | +$1.12M | 0.47% | 55 |
|
|
2024
Q3 | $84.7M | Buy |
1,283,979
+363,051
| +39% | +$24M | 0.43% | 64 |
|
|
2024
Q2 | $85.1M | Buy |
920,928
+32,422
| +4% | +$2.99M | 0.46% | 58 |
|
|
2024
Q1 | $84.9M | Buy |
888,506
+75,529
| +9% | +$7.22M | 0.49% | 52 |
|
|
2023
Q4 | $62M | Buy |
812,977
+90,025
| +12% | +$6.86M | 0.4% | 61 |
|
|
2023
Q3 | $50.1M | Buy |
722,952
+145,089
| +25% | +$10.1M | 0.36% | 65 |
|
|
2023
Q2 | $54.5M | Buy |
577,863
+36,865
| +7% | +$3.48M | 0.51% | 54 |
|
|
2023
Q1 | $44.8M | Buy |
540,998
+48,481
| +10% | +$4.01M | 0.46% | 59 |
|
|
2022
Q4 | $36.7M | Buy |
492,517
+52,724
| +12% | +$3.93M | 0.41% | 64 |
|
|
2022
Q3 | $36.3M | Buy |
439,793
+8,919
| +2% | +$737K | 0.45% | 58 |
|
|
2022
Q2 | $41M | Buy |
430,874
+28,635
| +7% | +$2.72M | 0.47% | 58 |
|
|
2022
Q1 | $47.4M | Buy |
402,239
+10,101
| +3% | +$1.19M | 0.48% | 52 |
|
|
2021
Q4 | $50.8M | Buy |
392,138
+26,049
| +7% | +$3.37M | 0.49% | 55 |
|
|
2021
Q3 | $41.4M | Buy |
366,089
+49
| +0% | +$5.55K | 0.45% | 58 |
|
|
2021
Q2 | $37.9M | Buy |
366,040
+49,435
| +16% | +$5.12M | 0.42% | 60 |
|
|
2021
Q1 | $26.5M | Buy |
316,605
+82,311
| +35% | +$6.88M | 0.34% | 75 |
|
|
2020
Q4 | $21.4M | Buy |
234,294
+121,929
| +109% | +$11.1M | 0.3% | 78 |
|
|
2020
Q3 | $8.97M | Buy |
112,365
+86,020
| +327% | +$6.87M | 0.15% | 95 |
|
|
2020
Q2 | $1.82M | Buy |
26,345
+24,838
| +1,648% | +$1.72M | 0.04% | 170 |
|
|
2020
Q1 | $284K | Buy |
+1,507
| New | +$284K | 0.01% | 253 |
|